The Shotlee Journal
Browse Shotlee articles about Mounjaro.
Showing 9 / 799 Mounjaro articles
Originally developed for diabetes, GLP-1 medications are now revealing profound insights into the neurobiology of desire, reward, and compulsion, impacting everything from food cravings to addictive tendencies.
A landmark study suggests semaglutide may protect bone strength while aiding weight loss, offering new hope for diabetes management and bone health.
A new study reveals BRP, a natural peptide, may offer the benefits of Ozempic without common side effects.
A comprehensive review of the latest clinical data comparing Tirzepatide, Semaglutide, and Liraglutide to determine the most effective option for significant weight reduction.
While known for diabetes and weight management, GLP-1 receptor agonists like Ozempic and Wegovy might have a surprising effect on impulse control and behavior, according to emerging research.
While GLP-1 agonists like Ozempic and Wegovy are celebrated for weight loss and blood sugar control, a recent study suggests a surprising benefit: improved bone health and a reduced risk of fractures in adults with Type 2 diabetes.
A groundbreaking analysis of diabetes medication patterns reveals that stopping isn't always permanent. Discover which drugs have the best retention rates and how insurance impacts access.
A comprehensive review of clinical trials suggests that GLP-1 medications may offer reproductive benefits for men with obesity-related low testosterone, potentially surpassing traditional hormone replacement therapies.
Groundbreaking research indicates that GLP-1 receptor agonists, widely recognized for their impact on diabetes and weight management, may also play a crucial role in modulating impulsive behaviors that can lead to criminal acts and violence.
